166 related articles for article (PubMed ID: 10609781)
1. P15INK4b gene methylation and myelodysplastic syndromes.
Quesnel B; Fenaux P
Leuk Lymphoma; 1999 Nov; 35(5-6):437-43. PubMed ID: 10609781
[TBL] [Abstract][Full Text] [Related]
2. Methylation status of the p15INK4B gene in hematopoietic progenitors and peripheral blood cells in myelodysplastic syndromes.
Aoki E; Uchida T; Ohashi H; Nagai H; Murase T; Ichikawa A; Yamao K; Hotta T; Kinoshita T; Saito H; Murate T
Leukemia; 2000 Apr; 14(4):586-93. PubMed ID: 10764143
[TBL] [Abstract][Full Text] [Related]
3. High-risk myelodysplastic syndromes and hypermethylation of the p15Ink4B gene.
Uchida T; Kinoshita T; Hotta T; Murate T
Leuk Lymphoma; 1998 Dec; 32(1-2):9-18. PubMed ID: 10036997
[TBL] [Abstract][Full Text] [Related]
4. Relationship between methylation of the p15 gene and ectopic expression of the EVI-1 gene in myelodysplastic syndromes (MDS).
Ohashi H; Tsushita K; Utsumi M; Shimoyama M; Murate T; Uchida T; Aoki E; Saito H; Kinoshita T
Leukemia; 2001 Jun; 15(6):990-1. PubMed ID: 11417490
[No Abstract] [Full Text] [Related]
5. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression.
Quesnel B; Guillerm G; Vereecque R; Wattel E; Preudhomme C; Bauters F; Vanrumbeke M; Fenaux P
Blood; 1998 Apr; 91(8):2985-90. PubMed ID: 9531610
[TBL] [Abstract][Full Text] [Related]
6. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
Quesnel B
Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the p15INK4B gene in myelodysplastic syndromes.
Uchida T; Kinoshita T; Nagai H; Nakahara Y; Saito H; Hotta T; Murate T
Blood; 1997 Aug; 90(4):1403-9. PubMed ID: 9269757
[TBL] [Abstract][Full Text] [Related]
9. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment.
Daskalakis M; Nguyen TT; Nguyen C; Guldberg P; Köhler G; Wijermans P; Jones PA; Lübbert M
Blood; 2002 Oct; 100(8):2957-64. PubMed ID: 12351408
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of p16INK4a and deletion of p15INK4b are frequent events in human esophageal cancer in Linxian, China.
Xing EP; Nie Y; Wang LD; Yang GY; Yang CS
Carcinogenesis; 1999 Jan; 20(1):77-84. PubMed ID: 9934853
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B.
Herman JG; Jen J; Merlo A; Baylin SB
Cancer Res; 1996 Feb; 56(4):722-7. PubMed ID: 8631003
[TBL] [Abstract][Full Text] [Related]
12. [Methylation of P15INK4B gene in patients with myelodysplastic syndromes and demethylating effects of drugs].
Ye XS; Liu T; Cui X; Meng WT; Xi YM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):57-9. PubMed ID: 17294728
[TBL] [Abstract][Full Text] [Related]
13. Methylation of the p15(INK4B) gene in myelodysplastic syndrome: it can be detected early at diagnosis or during disease progression and is highly associated with leukaemic transformation.
Tien HF; Tang JH; Tsay W; Liu MC; Lee FY; Wang CH; Chen YC; Shen MC
Br J Haematol; 2001 Jan; 112(1):148-54. PubMed ID: 11167795
[TBL] [Abstract][Full Text] [Related]
14. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.
Iwai M; Kiyoi H; Ozeki K; Kinoshita T; Emi N; Ohno R; Naoe T
Leukemia; 2005 Aug; 19(8):1367-75. PubMed ID: 15902282
[TBL] [Abstract][Full Text] [Related]
15. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
16. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of DNA methyltransferase genes do not correlate with p15INK4B gene methylation in myelodysplastic syndromes.
Aoki E; Ohashi H; Uchida T; Murate T; Saito H; Kinoshita T
Leukemia; 2003 Sep; 17(9):1903-4. PubMed ID: 12970793
[No Abstract] [Full Text] [Related]
19. P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients.
Preisler HD; Li B; Chen H; Fisher L; Nayini J; Raza A; Creech S; Venugopal P
Leukemia; 2001 Oct; 15(10):1589-95. PubMed ID: 11587217
[TBL] [Abstract][Full Text] [Related]
20. P53, p15INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia.
Güran S; Bahçe M; Beyan C; Korkmaz K; Yalçin A
Haematologia (Budap); 1998; 29(3):181-93. PubMed ID: 10069444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
